Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

BAY-1797

  Cat. No.:  DC26183   Featured
Chemical Structure
2055602-83-8
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86 21 58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
BAY-1797 is a potent and selective P2X4 antagonist.
Cas No.: 2055602-83-8
Chemical Name: N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide
Synonyms: BAY-1797;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide;N-(4-(3-chlorophenoxy)-3-sulfamoylphenyl)-2-phenylacetamide;BDBM50506158
SMILES: ClC1=C([H])C([H])=C([H])C(=C1[H])OC1C([H])=C([H])C(=C([H])C=1S(N([H])[H])(=O)=O)N([H])C(C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])=O
Formula: C20H17ClN2O4S
M.Wt: 416.8780
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO
Cat. No. Product name Field of application
DC36456 DMPAC-Chol DMPAC-Chol is a cationic cholesterol derivative that has been used in liposome formation for gene transfection. Liposomes containing DMPAC-chol bind to DNA in a band shift assay and protect against serum nuclease degradation of DNA.
DC33984 Biotin alkyne Biotin alkyne for the preparation of various biotinylated conjugates via Click Chemistry. This alkyne reacts with various azides, including biomolecules containing azide groups. Biotinylated conjugates can be used for various assays and applications requiring affinity binding. Our recommended protocol can be used for the conjugation.
DC32733 VH032-linker 5 VH032-linker 5 is a derivative of the proteolysis-targeting chimera technology (PROTAC) for PROTAC research and development; by incorporating an E3 ligase ligand and an alkyl C4 linker with terminal carboxylic acid, it is ready for conjugation to a target protein ligand.
DC32732 VH 032-linker 6 VH 032 Linker 6 is a derivative of the proteolysis-targeting chimera technology (PROTAC) for PROTAC research and development; by incorporating an E3 ligase ligand and a PEG2 linker with terminal alkyne, it is ready for conjugation to a target protein ligand
DC26169 MS1943 MS1943 is a first-in-class, orally bioavailable EZH2 selective degrader, with an IC50 of 120 nM. MS1943 significantly reduces EZH2 protein levels in numerous triple-negative breast cancer (TNBC) and other cancer and noncancerous cell lines.
DC26183 BAY-1797 BAY-1797 is a potent and selective P2X4 antagonist.
DC26119 VHL ligand 2 hydrochloride VHL ligand 2 hydrochloride) is the (S,R,S)-AHPC-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. (S,R,S)-AHPC-Me hydrochloride can be used to synthesize ARV-771, a von Hippel-Landau (VHL) E3 ligase-based BET PROTAC degrader.
DC26127 VHL ligand 1 (TFA) VHL ligand 1 TFA is the VH032-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein.
DC21962 TL13-12 TL13-12 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of TAE684 and the cereblon ligand pomalidomide.
DC21961 TL13-112 TL13-112 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of LDK378 and the cereblon ligand pomalidomide.
X